Table 1.
Patient characteristics
| Variable | Overall (N = 69) | |
|---|---|---|
| n | (%) | |
| Age (years)—median (min–max) | 69 | (36–73) |
| Sex | ||
| Female | 16 | (23.2%) |
| Male | 53 | (76.8%) |
| Tumour IIIb stage | ||
| T1 N3 M0 | 5 | (7.2%) |
| T2 N3 M0 | 18 | (26.1%) |
| T3 N3 M0 | 4 | (5.8%) |
| T4 N0 M0 | 18 | (26.1%) |
| T4 N1 M0 | 2 | (2.9%) |
| T4 N2 M0 | 17 | (24.6%) |
| T4 N3 M0 | 5 | (7.2%) |
| Lymph-node staging by mediastinoscopy | ||
| No | 1 | (1.4%) |
| Yes | 57 | (82.6%) |
| Not available | 11 | (15.9%) |
| Patient considered operable | ||
| Yes | 69 | (100.0%) |
| WHO PS at entry | ||
| 0 | 46 | (66.7%) |
| 1 | 23 | (33.3%) |
| Intervention planned at Tumour-board before inclusion | ||
| Bilobectomy | 11 | (15.9%) |
| Lobectomy | 36 | (52.2%) |
| Pneumonectomy | 15 | (21.7%) |
| Missing | 7 | (10.1%) |
| Histology | ||
| Adeno-NSCLC | 34 | (49.3%) |
| Large-cell NSCLC | 1 | (1.5%) |
| Poorly differentiated NSCLC | 5 | (7.2%) |
| Squamous NSCLC | 28 | (40.6%) |
| Missinga | 1 | (1.5%) |
| Pack-years of smoking—median (min–max) | 40 | (3–150) |
aHistology of tumour could not be defined in pathology report as material was not sufficient for evaluation